| Drug-Target Information | ||||||||
|---|---|---|---|---|---|---|---|---|
| Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
| otx-015 | bromodomain-containing protein 2 | NA | Clinical trial target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Malignant Neoplasms[MeSHID:D009369] Leukemia Myelocytic Acute[MeSHID:D015470] MYELODYSPLASTIC SYNDROME[MeSHID:D009190] |
1.77 | phase 1/2 | unknown |
| otx-015 | bromodomain-containing protein 4 | NA | Clinical trial target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Malignant Neoplasms[MeSHID:D009369] Leukemia Myelocytic Acute[MeSHID:D015470] MYELODYSPLASTIC SYNDROME[MeSHID:D009190] |
2.81 | phase 1/2 | unknown |
| click here to return to the previous page | ||||||||